Federal patent authorities rejected Genentech Inc.'s claim of rights over key biotechnology manufacturing techniques, a decision that could cost the South San Francisco company more than $100 million in revenue if upheld.
Genentech is appealing.
Thursday, February 22, 2007
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment